Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton

European Journal of Nuclear Medicine

Volumn 29, Issue 4, 2002, Pages 494-498

  Soerdjbalie Maikoe, Vidya ^a   Pelger, Rob C ^a   Lycklama à Nijeholt, Guus A ^a   Arndt, Jan Willem ^a   Zwinderman, Aeilko H ^a   Papapoulos, Socrates E ^a   Hamdy, Neveen A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hormone refractory metastatic prostate cancer; Local radiotherapy; Olpadronate; Spinal cord compression; Strontium 89

Indexed keywords

OLPADRONIC ACID; STRONTIUM 89;

ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASTRATION; CONTROLLED STUDY; DISEASE COURSE; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PALLIATIVE THERAPY; PROSTATE CANCER; SKELETON; SPINAL CORD COMPRESSION; DRUG EFFECT;

AGED; COMBINED MODALITY THERAPY; DIPHOSPHONATES; HUMANS; LUMBAR VERTEBRAE; MALE; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS; STRONTIUM; THORACIC VERTEBRAE; TREATMENT OUTCOME;

EID: 0036204649     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0728-7     Document Type: Article

References (38)

1. Cancer statistics
2. Experiences with metastatic neoplasms involving the spinal cord
3. Management of spinal cord compression
4. Epidural spinal cord compression from metastatic tumors: Diagnosis and treatment
5. Epidural metastases in prospectively evaluated veterans with cancer and back pain
6. Spinal cord compression secondary to prostate carcinoma: Treatment and prognosis
7. Adenocarcinoma of the prostate and metastatic medullary compression
8. Spinal cord compression with special reference to metastatic epidural tumors
9. Manifestations of advanced prostatic cancer: Prognosis and treatment
10. Characteristics of spinal cord compression in adenocarcinoma of prostate
11. Epidural cord compression in association with genitourinary neoplasms
12. The palliative management of skeletal metastases in prostate cancer: Use of bone-seeking radionuclides and bisphosphonates
13. Unsealed source therapy of painful bone metastases: An update
14. 89Sr-therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: A preliminary report
15. Strontium-89 therapy for the pain of osseous metastases
16. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
17. An evaluation of the safety and efficacy of treatment with strontium-89 in patients who have previously received wide field radiotherapy
18. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
19. Clinical experience with strontium-89 in prostatic and breast cancer patients
20. The effect of repeated strontium-8 chloride therapy on bone palliation in patients with skeletal cancer metastases
21. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine-resistant metastatic prostate cancer
22. Strontium-89 therapy for the palliation of pain due to osseous metastases
23. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer
24. Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton
25. Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate
26. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate (dimethyl-APD)
27. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
28. Bisphosphonates in the management of prostatic carcinoma metastatic to the skeleton
29. A caution about the use of MRI to diagnose spinal cord compression
30. Malignant bone pain: Pathophysiology and treatment
31. Selective accumulation of strontium-89 in metastatic deposits in bone: Radiohistologic correlation
32. Strontium-89 therapy: Measurement of absorbed dose to skeletal metastases
33. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia
34. Generalized increase in bone resorption in carcinoma of the prostate
35. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption
36. Morphometric evidence for bone resorption and replacement in prostate cancer
37. The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double blind randomised placebo-controlled study
38. Pyridinium cross-links as urinary markers of bone metastases in patients with prostate cancer